Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Alexis F, Pridgen E, Molnar LK, Farokhzad OC.

Mol Pharm. 2008 Jul-Aug;5(4):505-15. doi: 10.1021/mp800051m. Review.

2.

Surface engineering of inorganic nanoparticles for imaging and therapy.

Nam J, Won N, Bang J, Jin H, Park J, Jung S, Jung S, Park Y, Kim S.

Adv Drug Deliv Rev. 2013 May;65(5):622-48. doi: 10.1016/j.addr.2012.08.015. Review.

PMID:
22975010
3.

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE.

Mol Pharm. 2008 Jul-Aug;5(4):487-95. doi: 10.1021/mp800032f. Review.

4.

Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

Ernsting MJ, Murakami M, Roy A, Li SD.

J Control Release. 2013 Dec 28;172(3):782-94. doi: 10.1016/j.jconrel.2013.09.013. Review.

5.

Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Duan X, Li Y.

Small. 2013 May 27;9(9-10):1521-32. doi: 10.1002/smll.201201390. Review.

PMID:
23019091
6.

Control of polymeric nanoparticle size to improve therapeutic delivery.

Hickey JW, Santos JL, Williford JM, Mao HQ.

J Control Release. 2015 Dec 10;219:536-47. doi: 10.1016/j.jconrel.2015.10.006. Review.

PMID:
26450667
7.

PRINT: a novel platform toward shape and size specific nanoparticle theranostics.

Perry JL, Herlihy KP, Napier ME, Desimone JM.

Acc Chem Res. 2011 Oct 18;44(10):990-8. doi: 10.1021/ar2000315. Review.

8.

Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

Yoo JW, Chambers E, Mitragotri S.

Curr Pharm Des. 2010 Jul;16(21):2298-307. Review.

PMID:
20618151
9.

The importance of nanoparticle shape in cancer drug delivery.

Truong NP, Whittaker MR, Mak CW, Davis TP.

Expert Opin Drug Deliv. 2015 Jan;12(1):129-42. doi: 10.1517/17425247.2014.950564. Review.

PMID:
25138827
10.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Review.

PMID:
25813885
11.

Nanobiotechnology-based drug delivery in brain targeting.

Dinda SC, Pattnaik G.

Curr Pharm Biotechnol. 2013;14(15):1264-74. Review.

PMID:
24910011
12.

Polymeric nano-micelles: versatile platform for targeted delivery in cancer.

Mohamed S, Parayath NN, Taurin S, Greish K.

Ther Deliv. 2014 Oct;5(10):1101-21. doi: 10.4155/tde.14.69. Review.

PMID:
25418269
13.

Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.

Murugan K, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V.

Int J Nanomedicine. 2015 Mar 18;10:2191-206. doi: 10.2147/IJN.S75615. Review.

14.

Overcoming in vivo barriers to targeted nanodelivery.

Chrastina A, Massey KA, Schnitzer JE.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):421-37. doi: 10.1002/wnan.143. Review.

PMID:
21538941
15.

Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.

Cooper DL, Conder CM, Harirforoosh S.

Expert Opin Drug Deliv. 2014 Oct;11(10):1661-80. doi: 10.1517/17425247.2014.938046. Review.

PMID:
25054316
16.

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Owens DE 3rd, Peppas NA.

Int J Pharm. 2006 Jan 3;307(1):93-102. Review.

PMID:
16303268
17.

Polymeric micelles as drug carriers: their lights and shadows.

Yokoyama M.

J Drug Target. 2014 Aug;22(7):576-83. doi: 10.3109/1061186X.2014.934688. Review.

PMID:
25012065
18.
19.

Design attributes of long-circulating polymeric drug delivery vehicles.

Beck-Broichsitter M, Nicolas J, Couvreur P.

Eur J Pharm Biopharm. 2015 Nov;97(Pt B):304-17. doi: 10.1016/j.ejpb.2015.03.033. Review.

PMID:
25857838
20.

Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.

Song G, Wu H, Yoshino K, Zamboni WC.

J Liposome Res. 2012 Sep;22(3):177-92. doi: 10.3109/08982104.2012.655285. Review.

PMID:
22332871
Items per page

Supplemental Content

Support Center